On November 25, 2025, Adial Pharmaceuticals, Inc. entered into a warrant inducement agreement allowing the holder to exercise warrants for 9,215,675 shares at $0.31 each, generating approximately $2.86 million in proceeds. This event is significant for the company as it supports working capital efforts.